有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 3-benzyl-6-(3,4-dimethylphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | —— | C19H18N4S |
|
—— | 3-benzyl-6-(4-methylphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | —— | C18H16N4S |
|
—— | 6-(4-methylphenyl)-3-(thiophen-2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | —— | C15H12N4S2 |
|
—— | 2-[[5-(3-methyl-1,2-oxazol-5-yl)-4-[(1R)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C16H16N4O3S |
|
—— | 2-[[5-(3-methyl-1,2-oxazol-5-yl)-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C16H16N4O3S |
|
—— | (4R)-6-methyl-4-(5-methyl-1H-imidazol-4-yl)-2-oxo-N-(2-pyridin-2-ylsulfanylethyl)-3,4-dihydro-1H-pyrimidine-5-carboxamide | —— | C17H20N6O2S |
|
—— | (4S)-6-methyl-4-(5-methyl-1H-imidazol-4-yl)-2-oxo-N-(2-pyridin-2-ylsulfanylethyl)-3,4-dihydro-1H-pyrimidine-5-carboxamide | —— | C17H20N6O2S |
|
—— | (4R)-1-ethyl-4-[5-(1H-1,2,4-triazol-5-ylsulfanyl)furan-2-yl]-4,5-dihydro-2H-pyrazolo[3,4-b]pyridin-6-one | —— | C14H14N6O2S |
|
—— | 2-[[4-[(1R)-1-phenylethyl]-5-(pyridin-3-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C18H18N4O2S |
|
—— | (3S)-2,2-dimethyl-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]pyrrolidin-3-amine | —— | C10H20N6S |
|
—— | (3R)-2,2-dimethyl-N-[2-(1-methyltetrazol-5-yl)sulfanylethyl]pyrrolidin-3-amine | —— | C10H20N6S |
|
—— | 2-[[4-[(1S)-1-phenylethyl]-5-(pyridin-3-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C18H18N4O2S |
|
—— | (2R)-2-[(4-chloro-2-phenylsulfanyl-1,3-thiazol-5-yl)methylamino]butan-1-ol | —— | C14H17ClN2OS2 |
|
—— | 2-[[5-(1-ethylpyrazol-4-yl)-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C17H19N5O2S |
|
—— | 2-[[5-(1-ethylpyrazol-4-yl)-4-[(1R)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C17H19N5O2S |
|
—— | (6S)-6-[[5-(ethylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C15H17N3OS2 |
|
—— | (6R)-6-[[5-(ethylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C15H17N3OS2 |
|
—— | (6R)-6-(1-methyltetrazol-5-yl)sulfanyl-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C13H14N4OS |
|
—— | (6S)-6-[[4-(2-methoxyethyl)-1,2,4-triazol-3-yl]sulfanyl]-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C16H19N3O2S |
|
—— | (6S)-6-(1-methyltetrazol-5-yl)sulfanyl-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C13H14N4OS |
|
—— | (6S)-6-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C14H15N3OS |
|
—— | (6R)-6-[[4-(2-methoxyethyl)-1,2,4-triazol-3-yl]sulfanyl]-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C16H19N3O2S |
|
—— | (6R)-6-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-6,7,8,9-tetrahydrobenzo[7]annulen-5-one | —— | C14H15N3OS |
|
—— | N-[[(3S)-1-[2-(3,4-dimethylphenyl)sulfanylethyl]piperidin-3-yl]methyl]acetamide | —— | C18H28N2OS |
|
—— | N-[[(3R)-1-[2-(3,4-dimethylphenyl)sulfanylethyl]piperidin-3-yl]methyl]acetamide | —— | C18H28N2OS |
|
—— | N-[[(3R)-1-[(5-methylsulfanyl-2-sulfanylidene-1,3,4-thiadiazol-3-yl)methyl]piperidin-3-yl]methyl]acetamide | —— | C12H20N4OS3 |
|
—— | N-[[(3S)-1-[(5-methylsulfanyl-2-sulfanylidene-1,3,4-thiadiazol-3-yl)methyl]piperidin-3-yl]methyl]acetamide | —— | C12H20N4OS3 |
|
—— | (1R)-2-(5-bromopyrimidin-2-yl)sulfanyl-1-phenylethanol | —— | C12H11BrN2OS |
|
—— | (1S)-2-(5-bromopyrimidin-2-yl)sulfanyl-1-phenylethanol | —— | C12H11BrN2OS |
|
—— | 5-bromo-2-[1-[[(2S)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylpyrimidine | —— | C10H11BrN6OS |
|
—— | 5-bromo-2-[1-[[(2R)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylpyrimidine | —— | C10H11BrN6OS |
|
—— | 3-[(5-Methyl-2-piperidin-1-ium-1-ylidene-1,3-dithiol-4-yl)sulfanyl]propanoate | —— | C12H17NO2S3 |
|
—— | 2-[(3-Fluorophenyl)methylsulfanyl]-3,6-dimethylpyrimidin-4-one | —— | C13H13FN2OS |
|
—— | 3,6-Dimethyl-5-[(3-methylphenyl)methyl]-2-{[(2-methylphenyl)methyl]sulfanyl}-3,4-dihydropyrimidin-4-one | —— | C22H24N2OS |
|
—— | Tert-butyl 2-[1,4-dimethyl-5-[(2-methylphenyl)methyl]-6-oxopyrimidin-2-yl]sulfanylacetate | —— | C20H26N2O3S |
|
—— | 2-[(2,4-Difluorophenyl)methylsulfanyl]-5-[(3-fluorophenyl)methyl]-3,6-dimethylpyrimidin-4-one | —— | C20H17F3N2OS |
|
—— | 2-{[(3-Fluorophenyl)methyl]sulfanyl}-3,6-dimethyl-5-[(3-methylphenyl)methyl]-3,4-dihydropyrimidin-4-one | —— | C21H21FN2OS |
|
—— | 2-[(4-Fluorophenyl)methylsulfanyl]-3-methyl-6-propan-2-ylpyrimidin-4-one | —— | C15H17FN2OS |
|
—— | (3R,4R,6S)-6-(3-nitro-5-phenylsulfanylanilino)oxane-3,4-diol | —— | C17H18N2O5S |
|
—— | (2R)-2-[5-[(4-fluorophenyl)methyl]-1,4-dimethyl-6-oxopyrimidin-2-yl]sulfanyl-N-pentylpropanamide | —— | C21H28FN3O2S |
|
—— | (2S)-2-[5-[(4-fluorophenyl)methyl]-1,4-dimethyl-6-oxopyrimidin-2-yl]sulfanyl-N-pentylpropanamide | —— | C21H28FN3O2S |
|
—— | (3R,4R,6R)-6-(3-nitro-5-phenylsulfanylanilino)oxane-3,4-diol | —— | C17H18N2O5S |
|
—— | (3R,4S,6S)-6-(3-nitro-5-phenylsulfanylanilino)oxane-3,4-diol | —— | C17H18N2O5S |
|
—— | (3R,4S,6R)-6-(3-nitro-5-phenylsulfanylanilino)oxane-3,4-diol | —— | C17H18N2O5S |
|
—— | (2R,6R)-2,6-dimethyl-4-(3-phenylsulfanylpropyl)morpholine | —— | C15H23NOS |
|
—— | 2-[2-(4-fluorophenyl)-6-methylpyrimidin-4-yl]sulfanyl-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C23H24FN3OS |
|
—— | 2-[2-(3-fluorophenyl)-6-methylpyrimidin-4-yl]sulfanyl-N-[(2S)-4-phenylbutan-2-yl]acetamide | —— | C23H24FN3OS |
|
—— | (2S,6S)-2,6-dimethyl-4-[2-[2-(4-methylphenyl)sulfanylethoxy]ethyl]morpholine | —— | C17H27NO2S |
|
—— | (3S,5R)-3,5-dimethyl-1-[2-(2-phenylsulfanylethoxy)ethyl]piperidin-1-ium | —— | C17H28NOS+ |
|
—— | (2R,6R)-2,6-dimethyl-4-[3-(4-methylphenyl)sulfanylpropyl]morpholin-4-ium | —— | C16H26NOS+ |
|